| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| | 2025 | 2024 | GENETAG TECHNOLOGY, INC | 2421 KINGS ARMS DR NE | ATLANTA | GA | 30345-2132 | DEKALB | USA | R21AI169164 | Development of a dual-iDDS probe multiplex test for detecting endemic fungal agents | 000 | 2 | NIH | 4/21/2025 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $95,500 ) |
| | 2024 | 2024 | GENETAG TECHNOLOGY, INC. | 2421 KINGS ARMS DR | ATLANTA | GA | 30345-2132 | DEKALB | USA | R21AI169164 | Development of a dual-iDDS probe multiplex test for detecting endemic fungal agents | 000 | 2 | NIH | 12/13/2023 | $85,950 |
| | 2024 | 2024 | GENETAG TECHNOLOGY, INC | 2421 KINGS ARMS DR NE | ATLANTA | GA | 30345-2132 | DEKALB | USA | R21AI169164 | Development of a dual-iDDS probe multiplex test for detecting endemic fungal agents | 001 | 2 | NIH | 4/19/2024 | $9,550 |
| | 2024 | 2022 | GENETAG TECHNOLOGY, INC | 2421 KINGS ARMS DR NE | ATLANTA | GA | 30345-2132 | DEKALB | USA | R43EY034054 | Developing a multiplex diagnostic test for SNPs related to dry eye disease | 000 | 1 | NIH | 4/22/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $207,000 ) |
| | 2023 | 2023 | GENETAG TECHNOLOGY, INC. | 2421 KINGS ARMS DR | ATLANTA | GA | 30345-2132 | DEKALB | USA | R21AI169164 | Development of a dual-iDDS probe multiplex test for detecting endemic fungal agents | 000 | 1 | NIH | 12/6/2022 | $207,000 |
| | 2023 | 2021 | GENETAG TECHNOLOGY, INC. | 2421 KINGS ARMS DR | ATLANTA | GA | 30345-2132 | DEKALB | USA | R43AI156961 | Detecting drug-resistant HBV and HCV variants using a DDS probe array | 000 | 1 | NIH | 4/13/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $258,109 ) |
| | 2022 | 2022 | GENETAG TECHNOLOGY, INC. | 2421 KINGS ARMS DR | ATLANTA | GA | 30345-2132 | DEKALB | USA | R43EY034054 | Developing a multiplex diagnostic test for SNPs related to dry eye disease | 000 | 1 | NIH | 7/22/2022 | $258,109 |
|
| Issue Date FY: 2021 ( Subtotal = $253,385 ) |
| | 2021 | 2021 | GENETAG TECHNOLOGY, INC. | 2421 KINGS ARMS DR | ATLANTA | GA | 30345-2132 | DEKALB | USA | R43AI156961 | Detecting drug-resistant HBV and HCV variants using a DDS probe array | 000 | 1 | NIH | 2/2/2021 | $253,385 |
| | 2021 | 2020 | GENETAG TECHNOLOGY, INC. | 2421 KINGS ARMS DR | ATLANTA | GA | 30345-2132 | DEKALB | USA | R43AI150530 | Super-sensitive detection of universal markers of allograft rejection | 000 | 1 | NIH | 6/11/2021 | $0 |
| | 2021 | 2019 | GENETAG TECHNOLOGY, INC. | 2421 KINGS ARMS DR | ATLANTA | GA | 30345-2132 | DEKALB | USA | R43CA232276 | Super-sensitive detection of EGFR mutants driving lung cancer recurrence | 000 | 1 | NIH | 10/14/2020 | $0 |
| | 2021 | 2019 | GENETAG TECHNOLOGY, INC. | 2421 KINGS ARMS DR | ATLANTA | GA | 30345-2132 | DEKALB | USA | R43CA235891 | Super-sensitive detection of BCR-ABL mutants driving CML recurrence | 000 | 1 | NIH | 2/21/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $242,610 ) |
| | 2020 | 2020 | GENETAG TECHNOLOGY, INC. | 2421 KINGS ARMS DR | ATLANTA | GA | 30345-2132 | DEKALB | USA | R43AI150530 | Super-sensitive detection of universal markers of allograft rejection | 000 | 1 | NIH | 1/16/2020 | $242,610 |
| | 2020 | 2019 | GENETAG TECHNOLOGY, INC. | 2421 KINGS ARMS DR | ATLANTA | GA | 30345-2132 | DEKALB | USA | R43IP001128 | Detecting species-specific bacterial meningitis markers with iDDS probes | 01 | 1 | CDC | 10/23/2019 | $0 |
| | 2020 | 2019 | GENETAG TECHNOLOGY, INC. | 2421 KINGS ARMS DR | ATLANTA | GA | 30345-2132 | DEKALB | USA | R43IP001128 | Detecting species-specific bacterial meningitis markers with iDDS probes | 02 | 1 | CDC | 8/21/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $710,222 ) |
| | 2019 | 2019 | GENETAG TECHNOLOGY, INC. | 2421 KINGS ARMS DR | ATLANTA | GA | 30345-2132 | DEKALB | USA | R43CA232276 | Super-sensitive detection of EGFR mutants driving lung cancer recurrence | 000 | 1 | NIH | 3/6/2019 | $242,611 |
| | 2019 | 2019 | GENETAG TECHNOLOGY, INC. | 2421 KINGS ARMS DR | ATLANTA | GA | 30345-2132 | DEKALB | USA | R43IP001128 | Detecting species-specific bacterial meningitis markers with iDDS probes | 00 | 1 | CDC | 8/1/2019 | $225,000 |
| | 2019 | 2019 | GENETAG TECHNOLOGY, INC. | 2421 KINGS ARMS DR | ATLANTA | GA | 30345-2132 | DEKALB | USA | R43CA235891 | Super-sensitive detection of BCR-ABL mutants driving CML recurrence | 000 | 1 | NIH | 9/3/2019 | $242,611 |
| | 2019 | 2017 | GENETAG TECHNOLOGY, INC. | 2421 KINGS ARMS DR | ATLANTA | GA | 30345-2132 | DEKALB | USA | R43CA221412 | Blood biopsy test for pan-cancer mutations with error-checking probes | 000 | 1 | NIH | 2/5/2019 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $0 ) |
| | 2018 | 2017 | GENETAG TECHNOLOGY, INC. | 2421 KINGS ARMS DR | ATLANTA | GA | 30345-2132 | DEKALB | USA | R43AI129078 | Discriminating viral and bacterial meningitis infections with iDDS probes | 000 | 1 | NIH | 4/20/2018 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $485,222 ) |
| | 2017 | 2017 | GENETAG TECHNOLOGY, INC. | 2421 KINGS ARMS DR | ATLANTA | GA | 30345-2132 | DEKALB | USA | R43CA221412 | Blood biopsy test for pan-cancer mutations with error-checking probes | 000 | 1 | NIH | 9/18/2017 | $242,611 |
| | 2017 | 2017 | GENETAG TECHNOLOGY, INC. | 2421 KINGS ARMS DR | ATLANTA | GA | 30345-2132 | DEKALB | USA | R43AI129078 | Discriminating viral and bacterial meningitis infections with iDDS probes | 000 | 1 | NIH | 1/2/2017 | $242,611 |
| | 2017 | 2015 | GENETAG TECHNOLOGY, INC. | 2421 KINGS ARMS DR | ATLANTA | GA | 30345-2132 | DEKALB | USA | R43CA200198 | iDDS probes detecting IDH mutants in brain cancer | 000 | 1 | NIH | 11/22/2016 | $0 |
| | 2017 | 2015 | GENETAG TECHNOLOGY, INC. | 2421 KINGS ARMS DR | ATLANTA | GA | 30345-2132 | DEKALB | USA | R43CA189335 | Novel probes detecting ROS1,ALK and RET fusions and mutations in NSCLC | 000 | 1 | NIH | 11/22/2016 | $0 |
|
| Issue Date FY: 2015 ( Subtotal = $485,222 ) |
| | 2015 | 2015 | GENETAG TECHNOLOGY INC | 2421 KINGS ARMS DRIVE | ATLANTA | GA | 30345 | DEKALB | USA | R43CA189335 | Novel probes detecting ROS1,ALK and RET fusions and mutations in NSCLC | 000 | 1 | NIH | 7/16/2015 | $242,611 |
| | 2015 | 2015 | GENETAG TECHNOLOGY INC | 2421 KINGS ARMS DRIVE | ATLANTA | GA | 30345 | DEKALB | USA | R43CA200198 | iDDS probes detecting IDH mutants in brain cancer | 000 | 1 | NIH | 8/5/2015 | $242,611 |
|
| Issue Date FY: 2011 ( Subtotal = $448,414 ) |
| | 2011 | 2011 | GENETAG TECHNOLOGY INC | 2421 KINGS ARMS DRIVE | ATLANTA | GA | 30345 | DEKALB | USA | R43AI090852 | DNA DETECTION SWITCH (DDS) PROBES FOR DIAGNOSIS OF MULTI-DRUG RESISTANT TUBERCULO | 000 | 2 | NIH | 6/6/2011 | $448,414 |
|
| Issue Date FY: 2010 ( Subtotal = $464,985 ) |
| | 2010 | 2010 | GENETAG TECHNOLOGY INC | 2421 KINGS ARMS DRIVE | ATLANTA | GA | 30345 | DEKALB | USA | R43AI090852 | DNA DETECTION SWITCH (DDS) PROBES FOR DIAGNOSIS OF MULTI-DRUG RESISTANT TUBERCULO | 000 | 1 | NIH | 5/19/2010 | $464,985 |
| | 2010 | 2009 | GENETAG TECHNOLOGY INC | 2421 KINGS ARMS DRIVE | ATLANTA | GA | 30345 | DEKALB | USA | R43AI081511 | NOVEL UNIVERSAL PROBES FOR MULTI-TARGET QPCR DETECTION OF AVIAN FLU | 000 | 1 | NIH | 2/8/2010 | $0 |
|
| Issue Date FY: 2009 ( Subtotal = $320,224 ) |
| | 2009 | 2009 | GENETAG TECHNOLOGY INC | 2421 KINGS ARMS DRIVE | ATLANTA | GA | 30345 | DEKALB | USA | R43AI081511 | NOVEL UNIVERSAL PROBES FOR MULTI-TARGET QPCR DETECTION OF AVIAN FLU | 001 | 1 | NIH | 9/7/2009 | $124,025 |
| | 2009 | 2009 | GENETAG TECHNOLOGY INC | 2421 KINGS ARMS DRIVE | ATLANTA | GA | 30345 | DEKALB | USA | R43AI081511 | NOVEL UNIVERSAL PROBES FOR MULTI-TARGET QPCR DETECTION OF AVIAN FLU | 000 | 1 | NIH | 2/4/2009 | $196,199 |
|
|
